2019
DOI: 10.1016/j.jorganchem.2019.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of cationic NHC copper(I) complexes coordinated to 2,2'-bis-pyridyl ligands

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 52 publications
0
7
0
Order By: Relevance
“…The SAR study revealed that presence of electron donor or withdrawing substituent on the pyridine ring of the cationic copper(I) complexes and unsubstituted 2,2’‐dipyridylamine have positive effect on cytotoxicity. Also, complexes having large fluorinated anions 214 e – f showed less activity due to its lipophilic nature [102] …”
Section: Medicinal Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…The SAR study revealed that presence of electron donor or withdrawing substituent on the pyridine ring of the cationic copper(I) complexes and unsubstituted 2,2’‐dipyridylamine have positive effect on cytotoxicity. Also, complexes having large fluorinated anions 214 e – f showed less activity due to its lipophilic nature [102] …”
Section: Medicinal Applicationsmentioning
confidence: 99%
“…Also, complexes having large fluorinated anions 214 e-f showed less activity due to its lipophilic nature. [102]…”
Section: Copperà Nhc Complexes As Anticancer Agentsmentioning
confidence: 99%
“…Reports include Ru(II)-and Au(I)-N-heterocyclic carbenes, 15,16 Ag(I)-NHCs, as antimicrobial and anticancer agents, 17,18 and Cu(I)-NHCs possessing remarkable anticancer activity. 19 Lepidilinelike platinum(II) complexes were also synthesized and were found to be active against cancer cells. 20,21 However, metal complexes of lepidiline A or C were not investigated for their antiproliferative potential against cancer cells, and none of the plant-derived lepidilines were tested against multidrug-resistant (MDR) cancer or multipotent stem cells.…”
Section: ■ Introductionmentioning
confidence: 99%
“…The emissive Cu­(I)–NHC (NHC = N -heterocyclic carbene) complexes have promising features in the electrochemical cell, medicinal and organic light-emitting diode (OLED) applications. Luminescent Cu­(I)–NHC complexes have created an impact in OLED technologies since the discovery of the first luminescent Cu­(I)–NHC complexes [Cu 2 (μ-Me-mbim) 2 ]­(PF 6 ) 2 [μ-Me-mbim = methylene linked bis­(NHC)] by Matsumoto and co-workers . Subsequently, Thompson and co-workers proposed a linear donor-bridge-acceptor design strategy and developed a new class of two-coordinate CAAC-Cu-Cz [CAAC = (5 R ,6 S )-2-(2,6-diisopropylphenyl)-6-isopropyl-3,3,9-trimethyl-2-azaspiro-[4.5]­decan-2-ylidene, Cz = N -carbazolyl] complexes for mononuclear Cu­(I)-based thermally activated delayed fluorescence (TADF) systems for blue OLED with an external quantum efficiency (EQE) of 9%, emission at 474 nm .…”
Section: Introductionmentioning
confidence: 99%